⌘K
Loading ticker…
As of 2026-08-24, DNA X, Inc. Common Stock (SONM) has a 3-month relative strength percentile of 15 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 34. The current market Stance is 47.8 (Neutral). Sector: Technology, ranked 2 of 11. Average daily range 9.3%, relative volume 0.69×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
SONM is in a stage 4 downtrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -17.9% / -33.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
SONM appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $20K notional.
Held by 1 ETFs · $20K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $20K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SONM Jan avg: 19.68% median: 4.35% win: 50% σ: 41.07% n: 4 2022-04-12 → 2026-07-31 | SONM Feb avg: -9.47% median: -6.67% win: 0% σ: 10.20% n: 4 2022-04-12 → 2026-07-31 | SONM Mar avg: 22.50% median: -6.30% win: 25% σ: 71.35% n: 4 2022-04-12 → 2026-07-31 | SONM Apr avg: -2.65% median: -13.61% win: 40% σ: 23.02% n: 5 2022-04-12 → 2026-07-31 | SONM May avg: -9.95% median: -11.21% win: 20% σ: 21.07% n: 5 2022-04-12 → 2026-07-31 | SONM Jun avg: 22.83% median: 16.78% win: 80% σ: 25.71% n: 5 2022-04-12 → 2026-07-31 | SONM Jul avg: -25.30% median: -34.14% win: 20% σ: 35.14% n: 5 2022-04-12 → 2026-07-31 | SONM Aug avg: -16.79% median: -21.63% win: 25% σ: 19.47% n: 4 2022-04-12 → 2026-07-31 (current) | SONM Sep avg: -4.93% median: 1.37% win: 50% σ: 20.54% n: 4 2022-04-12 → 2026-07-31 | SONM Oct avg: 7.35% median: 11.25% win: 75% σ: 15.38% n: 4 2022-04-12 → 2026-07-31 | SONM Nov avg: -17.02% median: -8.15% win: 0% σ: 22.87% n: 4 2022-04-12 → 2026-07-31 | SONM Dec avg: -10.85% median: -0.91% win: 50% σ: 23.12% n: 4 2022-04-12 → 2026-07-31 |